Tirzepatide, on the other hand, targets both GLP-1 and GIP receptors
Semaglutide, Ozempic, Wegovy, and Mounjaro are all recognized for having a substantial impact on the management of major weight-related conditions
SpringerLink Avraham SA, et al
Semaglutide (Wegovy) and tirzepatide (Zepbound) are the most clinically proven FDA-approved options, helping patients lose 15 to 25% of their body weight
In a clinical trial in pediatric patients aged 12 years and older with normal baseline heart rate, more patients treated with this drug compared to placebo had maximum changes in heart rate of 20 bpm or more (54% vs 39%)
Direct recommendation: two subscription lines at checkout, or phone-only cancellation, means close the tab